(DNLI) Denali Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Denali Therapeutics | (DNLI) share price targets
Complete technical analysis of Denali Therapeutics (DNLI) by charts plus indicators, forecast predictions and share price targets for Denali Therapeutics (DNLI)
Denali Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Denali Therapeutics is 1158640
Date | Daily Closing Price | Open | High | Low | Volume |
28 Thu Mar 2024 | 20.52 | 20.86 | 21.04 | 20.12 | 0.856 times |
27 Wed Mar 2024 | 20.77 | 20.05 | 20.92 | 19.85 | 0.692 times |
26 Tue Mar 2024 | 19.88 | 20.14 | 20.19 | 19.47 | 1.076 times |
25 Mon Mar 2024 | 19.87 | 19.37 | 19.96 | 19.35 | 0.805 times |
22 Fri Mar 2024 | 19.62 | 20.98 | 21.04 | 19.58 | 0.857 times |
21 Thu Mar 2024 | 21.00 | 21.53 | 21.60 | 20.92 | 1.013 times |
20 Wed Mar 2024 | 21.29 | 20.34 | 21.50 | 20.16 | 0.9 times |
19 Tue Mar 2024 | 20.54 | 19.94 | 20.62 | 19.83 | 0.851 times |
18 Mon Mar 2024 | 20.09 | 20.10 | 20.60 | 19.77 | 0.81 times |
15 Fri Mar 2024 | 20.13 | 19.71 | 20.35 | 19.66 | 1.924 times |
My analysis of stock is bearish for shortterm, and stock might move down till 20 or till 19.4. Use a stoploss of 20.54 and if the stock hits stoploss, then it can shoot up till 21.06
Share price targets for Denali Therapeutics (DNLI)
Target Type | Value |
Downside Target | 15.45 |
Downside Target | 15.90 |
Downside Target | 16.54 |
Downside Target | 17.87 |
Downside Target | 19.24 |
Upside Target | 21.04 |
Upside Target | 21.60 |
Upside Target | 21.87 |
Upside Target | 21.93 |
Upside Target | 22.49 |
Upside Target | 23.52 |
Upside Target | 23.81 |
Intraday share price targets for Denali Therapeutics (DNLI)
Target Type | Value |
Downside Intraday Target | 19.57 |
Downside Intraday Target | 18.61 |
Upside Intraday Target | 21.26 |
Upside Intraday Target | 21.99 |
Downside Intraday Target | 20.3 |
Weekly technical analysis of Denali Therapeutics (DNLI)
Date | Weekly Closing Price | Open | High | Low | Volume |
28 Thu Mar 2024 | 20.52 | 19.37 | 21.04 | 19.35 | 0.774 times |
22 Fri Mar 2024 | 19.62 | 20.10 | 21.60 | 19.58 | 0.775 times |
15 Fri Mar 2024 | 20.13 | 20.92 | 21.86 | 19.24 | 1.203 times |
08 Fri Mar 2024 | 20.93 | 21.41 | 21.87 | 19.96 | 0.477 times |
01 Fri Mar 2024 | 20.86 | 16.85 | 23.52 | 16.54 | 2.377 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Denali Therapeutics (DNLI)
Date | Monthly Closing Price | Open | High | Low | Volume |
28 Thu Mar 2024 | 20.52 | 19.99 | 21.87 | 19.24 | 0.749 times |
29 Thu Feb 2024 | 19.78 | 16.16 | 23.52 | 15.49 | 1.425 times |
31 Wed Jan 2024 | 16.01 | 21.12 | 21.93 | 15.90 | 0.889 times |
29 Fri Dec 2023 | 21.46 | 18.38 | 23.81 | 17.87 | 1.049 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Denali Therapeutics (DNLI)
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Denali Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Denali Therapeutics in short term but the sell signal is initial and weak.
Denali Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Denali Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Denali Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.34 and Denali Therapeutics (DNLI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Denali Therapeutics (DNLI) stock. Volume based technical analysis of Denali Therapeutics (DNLI) stock is negative.
Denali Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Denali Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Denali Therapeutics in short term but the sell signal is initial and weak.
Denali Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Denali Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Denali Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.34 and Denali Therapeutics (DNLI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Denali Therapeutics (DNLI) stock. Volume based technical analysis of Denali Therapeutics (DNLI) stock is negative.
Denali Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.